LINEAR PEPTIDES INHIBITING CK2-MEDIATED PHOSPHORYLATION AND COMPOSITIONS COMPRISING SAME

Linear peptides that inhibit phosphorylation mediated by the enzyme casein kinase 2 (CK2), which have an amino acid sequence selected from the group consisting of the sequences identified as SEQ ID NO: 45, SEQ ID NO: 49, SEQ ID NO: 50, and SEQ ID NO: 57 - SEQ ID NO: 62, as well as polypeptides compr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GUILLÉN NIETO, Gerardo, Enrique, GONZALEZ BLANCO, Sonia, PERERA NEGRIN, Yasser, BESADA PÉREZ, Vladimir, Armando, REYES ACOSTA, Osvaldo, GARAY PÉREZ, Hilda, Elisa, GONZÁLEZ LÓPEZ, Luis, Javier, MASFORROL GONZÁLEZ, Yordanka, PEREA RODRÍGUEZ, Silvio, Ernesto, CABALLERO MENÉNDEZ, Evelin
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Linear peptides that inhibit phosphorylation mediated by the enzyme casein kinase 2 (CK2), which have an amino acid sequence selected from the group consisting of the sequences identified as SEQ ID NO: 45, SEQ ID NO: 49, SEQ ID NO: 50, and SEQ ID NO: 57 - SEQ ID NO: 62, as well as polypeptides comprising said peptides and an intracellular penetrating peptide. A pharmaceutical composition comprising at least one of these linear peptides or polypeptides and a pharmaceutically acceptable excipient. The invention also discloses the use of said peptides or polypeptides for the manufacture of a drug, and a method of treating solid or liquid tumors where said drug is administered.